Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
LUND, Sweden, May 12, 2015 (GLOBE NEWSWIRE) -- The Board of Directors of Active Biotech AB (publ) has issued a notice to the Annual General Meeting, which is to take place at 5 p.m. on Thursday, June...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Styrelsen för Active Biotech AB (publ) har...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} The Board of Directors of Active Biotech AB...
-
LUND, Sweden, April 30, 2015 (GLOBE NEWSWIRE) -- Active Biotech's Annual Report 2014 is now available for download at www.activebiotech.com. The Annual Report will only be digitally...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Active Biotechs årsredovisning för 2014 finns nu...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Active Biotech's Annual Report 2014 is now...
-
JERUSALEM, Israel and LUND, Sweden, April 23, 2015 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) (TASE:TEVA) and Active Biotech (Stockholm:ACTI) today announced the first...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Phase II ARPEGGIO study design to be...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Utformningen av fas II-studien...
-
LUND, Sweden, April 23, 2015 (GLOBE NEWSWIRE) -- Laquinimod The pivotal CONCERTO clinical study is continuing according to plan and results are expected in 2016 Teva is holding a number of...